A Study to Evaluate the Bioequivalence of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection in Healthy Study Participants
Clinical trial NCT04255862 · TERMINATED
Trial details
- NCT number
- NCT04255862
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-12
- Primary completion
- 2021-04-26
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.